The protein tyrosine kinase-2 (PTK2) gene encodes focal adhesion kinase, a structural 1 protein involved in lateral transmission of muscle fiber force. We investigated 2 whether single nucleotide polymorphisms (SNPs) of the PTK2 gene were associated 3 with various indices of human skeletal muscle strength and the inter-individual 4 variability in the strength responses to resistance training. We determined unilateral 5 knee extension single repetition maximum (1-RM), maximum isometric voluntary 6 contraction (MVC) knee joint torque and quadriceps femoris muscle specific force 7 (maximum force per muscle physiological cross-sectional area), before and after 9-8 weeks of knee extension resistance training in 51 untrained young men. All 9 participants were genotyped for the PTK2 intronic rs7843014 A/C and 3' UTR rs7460 10 A/T SNPs. There were no genotype associations with baseline measures or post-11 training changes in 1-RM or MVC. Although the training-induced increase in specific 12 force was similar for all PTK2 genotypes, baseline specific force was higher in PTK2 13 rs7843014 AA and rs7460 TT homozygotes than in their respective rs7843014 C-(P 14 = 0.016) and rs7460 A-allele (P = 0.009) carriers. These associations between muscle 15 specific force and PTK2 SNPs suggest that inter-individual differences exist in the 16 way force is transmitted from the muscle fibers to the tendon. Therefore, our results 17 demonstrate for the first time the impact of genetic variation on the intrinsic strength 18 of human skeletal muscle. 19 20
INTRODUCTION 24
Muscle force is transmitted to the tendon along the length of a muscle fiber and also 25 laterally via attachments to the surrounding matrix of connective tissue (27) . It has 26 been suggested that an increase in lateral attachments after resistance training might 27 result in an enhanced muscle specific force [maximum force per physiological cross-28 sectional area (PCSA)] (7, 12) . Such attachments have been identified as intra-29 sarcolemmal protein complexes known as "costameres" (19) , which are associated 30 with the lateral transmission of muscle fiber force (6) . Thus, costameres could enable 31 each muscle fiber to act as multiple force-generating units, thus increasing the specific 32 force of the whole muscle. 33 34 Mechanical tension is essential in regulating costameric protein expression (29) and 35 resistance training is known to modulate the expression of costameric proteins, such 36 as desmin (32) , alpha-1-syntrophin and dystrophin (14) in humans, while focal 37 adhesion kinase (FAK) and paxillin expression and activity are increased in stretch-38 induced hypertrophied rooster skeletal muscle (11) . The integrin-associated tyrosine 39 kinase, FAK, has been shown to play a major role in costamere formation and 40 turnover (4, 20) and FAK expression is controlled at the level of the protein tyrosine 41 kinase-2 (PTK2) gene. Therefore, polymorphisms of the PTK2 gene could potentially 42 underpin the considerable inter-individual variability reported in untrained human 43 muscle specific force [ranging from 22 to 40 N·cm -2 (8) ], and in the training-induced 44 relative change in specific force, which varies between -5% and +39% (9) . 45
46
As muscle strength and training responses are important from a clinical perspective, 47 e.g. the response to rehabilitation following injury, we aimed to elucidate whether 48 single nucleotide polymorphisms (SNPs) of the PTK2 gene were associated with in 49 vivo muscle specific force and functional measures of strength, both before and after 50 resistance training. We hypothesized that two PTK2 SNPs (the intronic rs7843014 51 and the 3' UTR rs7460 SNP) would be associated with QF muscle specific force and 52 with the change in specific force following training. 53 54
MATERIALS AND METHODS 55
Participants 56
Fifty-one untrained Caucasian males, aged 20.3 ± 3.1 years, height 178.1 ± 5.6 cm, 57 body mass 75.4 ± 10.6 kg, body mass index (BMI) 23.7 ± 2.6 (mean ± SD) provided 58 written informed consent prior to their involvement in the study, which complied with 59 the Declaration of Helsinki and was approved by the local ethics committee of the 60 Manchester Metropolitan University. Study volunteers were excluded if their age was 61 outside the range of 18-39 years, they had a history of lower-limb fracture, had taken 62 part in strength training within the 12 months prior to the study, had used dietary 63 supplements or performance enhancing aids, or if they were considered to be in ill 64 health (determined by their responses to a health questionnaire). Participants were 65 familiarized with all test procedures and equipment within a 14-day period prior to the 66 baseline measurements. Phenotype data from these participants have been reported 67 previously (9) . 68
69
Habitual physical activity rating 70
The habitual physical activity rating (PAR) of each participant was assessed by 71 questionnaire (2) immediately prior to the training period. The overall PAR was 72 scored using a scale from 1 to 5 points, where 1 was the least active, 3 was 73 intermediate and 5 was extremely active. Participants were asked to maintain their 74 PAR and habitual dietary intake over the course of the study. 75
76

Experimental design 77
Maximum patellar tendon force, QF muscle volume, physiological cross-sectional 78 area (PCSA) and specific force were determined in the right limb [as described in 79 Method 2 of (8)] before and after nine weeks of high-intensity unilateral knee 80 extension resistance training (10) in 51 previously untrained men. In addition, all 81 participants had blood samples isolated, which were genotyped for the PTK2 rs7460 82 A/T and rs7843014 A/C SNPs. 83
84
Progressive resistance training 85
The supervised resistance training protocol has been described in detail elsewhere 86 (10) . Briefly, supervised knee extension training was performed unilaterally three 87 times per week for nine weeks. The maximum training load that could be lifted once 88 only (1-RM) throughout the full range of knee extension (110° to 20° of knee flexion; 89 0° = full knee extension) was assessed at the beginning of the training program and 90 re-evaluated at the start of each week on a standard knee extension machine 91 (Technogym, Gambettola, Italy). The training intensity was set in relation to the 1-92 RM and was therefore progressively increased throughout the nine weeks of training. 93
Each session comprised a warm-up set of 10 knee extension repetitions at 40% of the 94 revised 1-RM, followed by four sets (2 min rest between each) of 10 repetitions at 95 80% 1-RM. Compliance with the training protocol was 100%, with each participant 96 completing all 27 training sessions. 97
Maximum patellar tendon force 99
The method used to assess maximum patellar tendon force has been explained in 100 detail elsewhere (8) . In summary, participants performed isometric knee extension 101 maximal voluntary contractions (MVCs) on a dynamometer (Cybex Norm, Cybex 102
International, Ronkonkoma, NY) at optimum knee joint angle, which ranged from 70-103 90° knee flexion. Participants were seated with a hip angle of 85° (supine = 180°) and 104 were fixed with inextensible straps to the strength-testing chair. Co-contraction torque 105 of the antagonist muscles during knee extension MVC was calculated by comparing 106 electromyographic activity of the biceps femoris muscle during maximal isometric 107 knee extension and maximal isometric knee flexion (21) . Two bipolar silver chloride 108 surface electrodes (Neuroline, Medicotest, Rugmarken, Denmark) were placed 20 mm 109 apart along the sagittal axis over the muscle belly (the location was recorded on an 110 acetate for further tests) and one reference electrode was positioned over the lateral 111 tibial condyle. The root mean square of the raw EMG signal was calculated over one 112 second around the peak torque during each maximum voluntary isometric knee 113 extension and flexion at optimum joint angle and the torque produced by the 114 hamstrings during knee extension was estimated assuming a linear relationship 115 between torque and EMG activity (21) . The estimated antagonist torque obtained at 116 the optimum knee extension joint angle was used to calculate the maximum overall 117 knee extension torque. Voluntary QF muscle activation was assessed using the 118 interpolated twitch technique (25), whereby the participant received a supramaximal 119 twitch (Digitimer stimulator model DS7, Welwyn Garden City, UK) via two 7.5 cm x 120 12.5 cm self-adhesive electrodes (Versastim, Conmed, New York, NY) placed distally 121 (anode) and proximally (cathode) over the QF muscle, once before MVC (control 122 twitch) and once during MVC. True maximum torque (TMT) was calculated as: 123
where t is the amplitude of the superimposed twitch, T is the value of the twitch 125 before the MVC and MVC(C) is MVC corrected for antagonist muscle co-activation. 126
The percentage of voluntary muscle activation was given by: 127
The patellar tendon moment arm (d PT ) was determined using a 0.2-T magnetic 129 resonance imaging (MRI) scanner (G-Scan, Esaote Biomedica, Genoa, Italy), as 130 previously described (30) . Sagittal and coronal-plane knee scans were acquired using 131 a Turbo 3D T1-weighted sequence with the following scanning parameters: time of 132 repetition 40 ms; time to echo 16 ms; matrix 256 x 256; field of view 180 mm x 180 133 mm; slice thickness 3.4 mm; interslice gap 0 mm. The knee was scanned at rest with 134 the participant in the supine position and the knee fully extended. Coronal scans were 135 used to identify the appropriate sagittal scans, which were used to locate the centre of 136 rotation (COR), i.e. the midpoint of the shortest distance between the two femoral 137 condyles and the tibial plateau, and d PT was defined as the perpendicular distance 138 between the COR and the axis of the patellar tendon (30) . Previously reported ratios 139 of d PT at full extension (0 degrees knee flexion) to d PT at of 70, 80 and 90 degrees 140 knee flexion (3) were used to calculate d PT at optimum knee joint angle in this study. 141
Subsequently, maximum force resolved at the patellar tendon (F t ) was calculated as: 142
Muscle physiological cross-sectional area (PCSA) 145 QF muscle PCSA was determined from a method that has been described in detail 146 previously [Method 2 of (8)]. In brief, ultrasonography (MyLab25, Esaote Biomedica, 147 Genoa, Italy) was used to identify femur length (the distance from the proximal origin 148 of the VL muscle to the tibiofemoral contact point). ACSA of each component QF 149 muscle was assessed from transverse MRI scans acquired at 40% femur length from 150 the distal end. QF muscle volume (V m ) was calculated by adapting a previously 151 described method (15) that incorporated femur length, the ACSA of each constituent 152 QF muscle and a series of regression equations. VL muscle fascicle length (L f ) and 153 pennation angle (θ p ) were measured during knee extension MVC at optimum knee 154 angle using ultrasonography at 50% of the muscle length along the mid-sagittal plane. The habitual physical activity rating (PAR) for the total cohort was 2.7 ± 0.3 and can 230 be described as slightly less than "intermediate" (2) . Furthermore, none of the 231 physical characteristics (age, stature, body mass, BMI) or PAR differed between 232 genotype regarding either polymorphism: PTK2 rs7843014 A/C (P ≥ 0.135); rs7460 233 A/T (P ≥ 0.102). 234 235
Single repetition maximum (1-RM) 236
Baseline 1-RM (54.3 ± 11.0 kg for the whole cohort) did not differ between genotype 237 for both the rs7843014 (ANOVA, genotype P = 0.659; Table 1 ) and the rs7460 238 (ANOVA, genotype P = 0.740; Table 1 ) SNPs. Similarly, the % change in 1-RM 239 (+66.8 ± 30.2% for the entire group) did not differ between genotype for either SNP 240 (rs7843014: ANOVA, time x genotype P = 0.306; Table 1 ; rs7460: ANOVA, time x 241 genotype P = 0.839; Table 2 ). 242 Table 1 near here.  244 Before training, MVC torque (248 ± 52 N·m for the entire cohort) did not differ 247 between genotype regarding either the rs7843014 (ANOVA, genotype P = 0.826; 248 Table 1 ) or the rs7460 (ANOVA, genotype P = 0.697; Table 2 ) SNPs. In addition, the 249 % change in MVC torque (26.1 ± 10.7% for the whole group) did not differ between 250 genotype for either SNP (rs7843014: ANOVA, time x genotype P = 0.642; Table 1 ; 251 rs7460: ANOVA, time x genotype P = 0.553; Table 2 ). 252 253 
Muscle physiological cross-sectional area (PCSA) 256
Prior to training, QF muscle PCSA for the total cohort was 239 ± 40 cm 2 , and there 257 was no association with either SNP (ANOVA, genotype P ≥ 0.314). Nine weeks of 258 resistance training led to a 5.8 ± 4.5% increase in muscle PCSA (ANOVA, time P < 259 0.0005), which was independent of PTK2 genotype (ANOVA, time x genotype P ≥ 260 0.963). 261 262
Muscle specific force 263
Regarding untrained muscle specific force (25.5 ± 5.2 N·cm -1 for the entire group), 264 there were non-significant tendencies for PTK2 rs7843014 AA homozygotes to 265 produce higher muscle specific force than their AC and CC counterparts (ANOVA 266 genotype P = 0.078; Table 1 ), and the muscles of PTK2 rs7460 TT homozygotes to 267 have higher specific force than AA and AT genotypes (ANOVA, genotype P = 0.058; 268 Table 2 ). When the PTK2 rs7843014 AC and CC genotypes were pooled, the QF 269 muscles of individuals homozygous for the A-allele expressed higher specific force 270 than carriers of the C-allele before training (ANOVA, genotype P = 0.023; Table 1 ; t-271 test P = 0.016; Fig. 1) . Similarly, when the PTK2 rs7460 AA and AT genotypes were 272 combined, QF muscle specific force was found to be higher in TT homozygotes than 273 in A-allele carriers before training (ANOVA, genotype P = 0.017; Table 2 ; t-test P = 274 0.009; Fig. 1 ). However, there was no significant interaction between training and 275 PTK2 genotype concerning QF muscle specific force and both the rs7843014 276 (ANOVA, time x genotype P = 0.601; time P < 0.0005; Table 1 ) and rs7460 277 (ANOVA, time x genotype P = 0.461; time P < 0.0005; Table 2) As both SNPs of the PTK2 gene were associated with QF muscle specific force, and a 284 large proportion of participants (33%) possessed both 'preferential' genotypes, it was 285 further investigated whether or not the loci and PTK2 alleles were independent from 286 each other. The estimated haplotype frequencies are presented in Table 3 , and the 287 deviation of the observed haplotype frequency from the expected frequency was 288 calculated and defined as the linkage disequilibrium (LD). The LD for the two PTK2 289 polymorphisms was D' = 0.905 and R 2 = 0.700, which suggests that the two 290 polymorphisms are in LD and are not completely independent from one another. 291 292 Both PTK2 SNPs were associated with untrained muscle specific force, therefore the 295 contribution of each SNP to the inter-individual variance in the respective muscle 296 phenotype was investigated. On an individual basis, PTK2 rs7843014 genotype 297 correlated with baseline muscle specific force (R 2 = 0.091; P = 0.031), suggesting that 298 genotype for this SNP alone contributed to ~9% of the inter-individual variability in 299 muscle specific force in the untrained state. PTK2 rs7460 genotype also correlated 300 with baseline muscle specific force (R 2 = 0.102; P = 0.022), thus implying that 301 genotype for this SNP explained ~10% of the inter-individual variability in untrained 302 muscle specific force. Combining the two PTK2 SNPs in a multiple regression model 303 led to a tendency towards a correlation with untrained muscle specific force (R 2 = 304 0.105; P = 0.071). Although this correlation did not reach statistical significance, it is 305 interesting to note that the coefficient of determination was similar to that of the 306 individual PTK2 SNPs, which is probably due to the relatively high LD between the 307 two SNPs. 308
309
DISCUSSION 310
We investigated whether associations existed between polymorphisms of the PTK2 311 gene and human skeletal muscle strength phenotypes before and after resistance 312 training. The two PTK2 gene polymorphisms were significantly associated with the 313 inter-individual variability in muscle specific force but did not contribute to the 314 observed inter-individual variation in the training response. Thus, our results highlight 315 a novel association between sequence variations in the PTK2 gene and the intrinsic 316 force generating capacity of human skeletal muscle, possibly via influences on lateral 317 force transmission. It should be noted, however, that the data presented in this study 318 are preliminary in that the sample size is a limitation. Thus, future studies should 319 attempt to replicate our findings using larger cohorts from the same and other ethnic 320 populations, which would increase both the power of the study and the confidence in 321 our results. 322
323
The genotype frequencies for the PTK2 rs7843014 (AA = 37%; AC = 41%; CC = 324 22%) and rs7460 (AA = 26%; AT = 41%; TT = 33%) SNPs observed in our study 325 were comparable to those reported previously for Caucasian populations (31). 326
Baseline values for our entire cohort were similar to those reported elsewhere for this 327 population concerning 1-RM lifting strength (13) , isometric MVC knee joint torque 328 (18) , QF muscle PCSA (16) and specific force (16) . Our observed 67% increase in 1-329 RM for the whole cohort was higher than some (22), but less than other (23, 24) 330 reports of 1-RM strength gains following a similar period of knee extensor strength 331
training. The 26% increase in isometric knee extensor MVC strength was less than 332 some (26), but greater than other (1, 17) previously reported gains in isometric 333 strength following a similar duration of knee extensor training. Regarding muscle 334 hypertrophy, our observed 6% increase in QF muscle PCSA was comparable to 335 previous reports of QF muscle size gains following resistance training of similar type 336 and duration (1, 17) . The 16% increase in muscle specific force was also comparable 337 to that reported elsewhere following resistance training of the QF muscle, although in 338 older individuals (21) . 339 340 Focal adhesion kinase (FAK) plays an integral role in the costamere protein complex 341 (4, 20) that is involved in the lateral transmission of force (6) . As FAK is encoded by 342 the PTK2 gene, we hypothesized that polymorphisms of this gene would explain part 343 of the inter-individual variability in QF muscle specific force between untrained 344 young men. We determined that individuals homozygous for the rs7843014 A-allele 345 had a higher muscle specific force than carriers of the C-allele, while QF muscle 346 specific force was greater in rs7460 TT homozygotes compared to their A-allele 347 counterparts. a kind likely to influence the amino acid sequence of the protein product. However, an 361 alteration in DNA sequence in the 3'UTR region of a gene (e.g. the PTK2 rs7460 A/T 362 polymorphism) has the potential to alter the level, location or timing of gene 363 expression, while intronic genomic variants (e.g. the PTK2 rs7843014 A/C 364 polymorphism) generally have the potential to influence gene expression and mRNA 365 stability (28) . Therefore, a potential influence of PTK2 gene polymorphisms on the 366 concentration and time course of FAK expression warrants future investigation. 367
368
We hypothesized that PTK2 genotype would influence muscle specific force, leading 369 to associations with functional measures of strength, such as maximum dynamic 370 lifting strength (1-RM) and isometric MVC knee joint torque. While we did find 371 PTK2 genotype associations with untrained QF muscle specific force, we observed no 372 association with baseline 1-RM or MVC torque. Although the intrinsic strength of the 373 muscle undoubtedly contributes to both 1-RM and MVC torque, extrinsic factors such 374 as neural drive, moment arm length, muscle size and architecture are also known to 375 influence such strength measures independent of specific force (8) , thus potentially 376 masking any genotype associations with 1-RM and MVC torque. 377 378 Mechanical tension is known to regulate costameric protein expression (29) and 379 resistance training increases the expression of costameric proteins, such as desmin 380 (32) , alpha-1-syntrophin and dystrophin (14) in humans, and FAK in hypertrophied 381 rooster skeletal muscle (11) . Therefore, we hypothesized that PTK2 genotype would 382 influence the previously reported inter-individual variability in the training-induced 383 change in muscle specific force, 1-RM and MVC torque (9) , possibly through a 384 genotype-dependent change in costameric density with loading. However, we found 385 no association between either PTK2 SNP and the relative changes in muscle specific 386 force, 1-RM or MVC torque following 9 weeks of resistance training. If any inherent 387 difference between PTK2 genotype in the level of FAK protein expression is not 388 preferentially enhanced with loading, muscle specific force will increase similarly 389 between genotype. The higher muscle specific force at baseline might then be 390 attributable to a greater muscle costameric density, which could be realized by 1) a 391 higher number of costameres per muscle fiber perimeter and/or 2) a larger number of 392 smaller fibers per muscle with a higher fiber perimeter to area ratio. Preliminary 393 (unpublished) histological data from our laboratory suggest that people with the 394 'preferential' PTK2 AA genotype do have smaller muscle fiber CSAs than their 'non-395 preferential' genotype counterparts, and together with a non-association between 396 PTK2 genotype and muscle PCSA reported here, this would support the second 397 hypothesis. In this case, a larger loading-induced increase in FAK expression in 398 people with the higher baseline specific force, i.e. people with the 'preferential' PTK2 399 genotypes, might be offset by a relatively greater loading-induced increase in the 400 perimeter of large compared to small fibers (assuming a similar relative increase in 401 fiber CSA). This would lead to a similar increase in total muscle costameric density 402 between genotype, which in turn would lead to comparable training-induced increases 403 in muscle specific force. and preferential (black bars) genotypes of the protein tyrosine kinase-2 (PTK2) rs7843014 (preferential genotype: AA) and rs7460 (preferential genotype: TT); *P = 0.016 significantly different from pooled PTK2 rs7843014 AC + CC genotypes; **P = 0.009 significantly different from combined PTK2 rs7460 AA + AT genotypes.
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